mortality/aging
• die at 2-4 weeks of age
|
growth/size/body
• dilated
|
• cessation of weight gain from P10 onwards
|
cardiovascular system
• dilated
|
• ECG changes under isofluorane anesthesia
|
• decrease in peak aortic blood flow velocity under isofluorane anesthesia
|
homeostasis/metabolism
• levels of aconitase, a mitochondrial enzyme, and nucleus-encoded respiratory chain complex II are not affected
|
• total glutathione peroxidase enzyme activity is elevated in hearts
|
• ECG changes under isofluorane anesthesia
• decrease in peak aortic blood flow velocity under isofluorane anesthesia
|
behavior/neurological
bradykinesia
(
J:51964
)
• decreased spontaneous movement from P10 onwards
|
muscle
• mutants exhibit a significant increase in apoptosis of cardiomyocytes
• however, no evidence of fibrosis, necrosis, or inflammatory cell infiltration is seen in the hearts
|
cellular
• mutants exhibit a significant increase in apoptosis of cardiomyocytes
• however, no evidence of fibrosis, necrosis, or inflammatory cell infiltration is seen in the hearts
|
• mosaic respiratory chain deficiency in the myocardium
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Kearns-Sayre syndrome | DOID:12934 |
OMIM:530000 |
J:51964 |